Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 974.29 million compared to CNY 887.48 million a year ago. Net income was CNY 101.16 million compared to CNY 93.17 million a year ago.

Basic earnings per share from continuing operations was CNY 1.18 compared to CNY 1.09 a year ago. Diluted earnings per share from continuing operations was CNY 1.17 compared to CNY 1.09 a year ago.